Stocks News

LAST PRICE
35.4000
TODAY'S CHANGE (%)
Trending Up2.7500 (8.4227%)

Bid / Lots
35.0000/ 5
Ask / Lots
36.4000/ 1
Open / Previous Close
33.1400 / 32.6500
Day Range
Low 32.8900
High 36.0200
52 Week Range
Low 15.8100
High 37.0399
Volume
3,543,805
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 13, 2024
- Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  5:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: GH
  
  Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  PALO ALTO, Calif.--(BUSINESS WIRE)--November 13, 2024--
  Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 22, 2024, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units ("RSUs") representing 233,603 shares of its common stock to 123 new non-executive employees and non-qualified stock option awards to purchase an aggregate of 50,349 shares of its common stock to three new non-executive employees with a grant date of November 8, 2024 under the Guardant Health, Inc. 2023 Employment Inducement Incentive Award Plan (the "Inducement Plan"). The RSUs and stock options were granted as inducements material to the employees entering into employment with Guardant in accordance with Nasdaq Listing Rule 5635(c)(4).
Nov 7, 2024
- DJ Guardant Health Is Maintained at Overweight by JP Morgan, from 12:51PM ET on Thursday Nov 07, 2024 by Dow Jones
  12:51PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: GH
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 12:51 ET (17:51 GMT)
- DJ Guardant Health Is Maintained at Buy by Goldman Sachs, from 11:57AM ET on Thursday Nov 07, 2024 by Dow Jones
  11:57AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: GH
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 11:57 ET (16:57 GMT)
- Top Premarket Gainers, from 7:53AM ET on Thursday Nov 07, 2024 by MT Newswires
  7:53AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: GH, LYFT, EBS, APP, CYN
  07:53 AM EST, 11/07/2024 (MT Newswires) -- Cyngn (CYN) shares were up 50% pre-bell Thursday after the company's Q3 net loss narrowed overnight amid higher revenue. AppLovin (APP) stock was 32% higher after the company late Wednesday posted higher Q3...
Nov 6, 2024
- -- Earnings Flash (GH) GUARDANT HEALTH Reports Q3 Revenue $191.5M, from 4:07PM ET on Wednesday Nov 06, 2024 by MT Newswires
  4:07PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: GH
  04:07 PM EST, 11/06/2024 (MT Newswires) -- ...

Nov 20, 2024
- Inari Medical Insider Sold Shares Worth $3,069,521, According to a Recent SEC Filing, from 5:31PM ET on Wednesday Nov 20, 2024 by MT Newswires
  5:31PM ET on Wednesday Nov 20, 2024 by MT Newswires
  Companies Mentioned: NARI
Nov 19, 2024
- DJ Warby Parker Is Maintained at Outperform by Telsey Advisory Group, from 12:16PM ET on Tuesday Nov 19, 2024 by Dow Jones
  12:16PM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: WRBY
- INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Inari Medical, Inc. (NARI) and Encourages Long-Term NARI Investors to Contact the Firm, from 8:52AM ET on Tuesday Nov 19, 2024 by Newsfile
  8:52AM ET on Tuesday Nov 19, 2024 by Newsfile
  Companies Mentioned: NARI
- INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Inari Medical, Inc. (NARI) and Encourages Long-Term NARI Investors to Contact the Firm, from 8:52AM ET on Tuesday Nov 19, 2024 by Dow Jones
  8:52AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: NARI
Nov 15, 2024
- DJ Haemonetics Price Target Maintained With a $112.00/Share by Needham, from 2:30PM ET on Friday Nov 15, 2024 by Dow Jones
  2:30PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: HAE
Nov 13, 2024
- Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 1:09PM ET on Wednesday Nov 13, 2024 by Newsfile
  1:09PM ET on Wednesday Nov 13, 2024 by Newsfile
  Companies Mentioned: NARI
- Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 1:09PM ET on Wednesday Nov 13, 2024 by Dow Jones
  1:09PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: NARI
Nov 8, 2024
- DJ Warby Parker Is Maintained at Outperform by Telsey Advisory Group, from 6:09PM ET on Friday Nov 08, 2024 by Dow Jones
  6:09PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: WRBY
- DJ Haemonetics Is Maintained at Outperform by Barrington Research, from 4:22PM ET on Friday Nov 08, 2024 by Dow Jones
  4:22PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: HAE
- UBS Adjusts Price Target on Warby Parker to $20 From $15, Maintains Neutral Rating, from 11:55AM ET on Friday Nov 08, 2024 by MT Newswires
  11:55AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: WRBY

Guardant Health Inc
NASDAQ:GHUnited States

Search Criteria

Nov 13, 2024

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:05PM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 7, 2024

DJ Guardant Health Is Maintained at Overweight by JP Morgan, from 12:51PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Guardant Health Is Maintained at Buy by Goldman Sachs, from 11:57AM ET on Thursday Nov 07, 2024 by Dow Jones

Top Premarket Gainers, from 7:53AM ET on Thursday Nov 07, 2024 by MT Newswires

Nov 6, 2024

-- Earnings Flash (GH) GUARDANT HEALTH Reports Q3 Revenue $191.5M, from 4:07PM ET on Wednesday Nov 06, 2024 by MT Newswires

Peers Headlines

Nov 20, 2024

Inari Medical Insider Sold Shares Worth $3,069,521, According to a Recent SEC Filing, from 5:31PM ET on Wednesday Nov 20, 2024 by MT Newswires

Nov 19, 2024

DJ Warby Parker Is Maintained at Outperform by Telsey Advisory Group, from 12:16PM ET on Tuesday Nov 19, 2024 by Dow Jones

INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Inari Medical, Inc. (NARI) and Encourages Long-Term NARI Investors to Contact the Firm, from 8:52AM ET on Tuesday Nov 19, 2024 by Newsfile

INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Inari Medical, Inc. (NARI) and Encourages Long-Term NARI Investors to Contact the Firm, from 8:52AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 15, 2024

DJ Haemonetics Price Target Maintained With a $112.00/Share by Needham, from 2:30PM ET on Friday Nov 15, 2024 by Dow Jones

Nov 13, 2024

Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 1:09PM ET on Wednesday Nov 13, 2024 by Newsfile

Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 1:09PM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 8, 2024

DJ Warby Parker Is Maintained at Outperform by Telsey Advisory Group, from 6:09PM ET on Friday Nov 08, 2024 by Dow Jones

DJ Haemonetics Is Maintained at Outperform by Barrington Research, from 4:22PM ET on Friday Nov 08, 2024 by Dow Jones

UBS Adjusts Price Target on Warby Parker to $20 From $15, Maintains Neutral Rating, from 11:55AM ET on Friday Nov 08, 2024 by MT Newswires